Title

Docetaxel as monotherapy or combined with ramucirumab or icrucumab in second-line treatment for locally advanced or metastatic urothelial carcinoma: an open-label, three-arm, randomized controlled phase II trial

Document Type

Journal Article

Publication Date

5-2016

Journal

Journal of Clinical Oncology

Volume

34

Issue

13

Inclusive Pages

1500-1509

DOI

10.1200/JCO.2015.65.0218

Peer Reviewed

1